{
  "created_at": "Thu May 13 1:24:40 +0000 2021",
  "id_str": "1392597617352261641",
  "full_text": "Confirmed cases of rare but serious blood clotting among recipients of Johnson &amp; Johnson's Covid-19 vaccine have risen and included some men for the first time. Health officials said that the shot’s benefits still outweigh the risk. https://t.co/vZavrNQ8in",
  "display_text_range": [
    0,
    260
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/vZavrNQ8in",
        "expanded_url": "https://on.wsj.com/2RLhnsY",
        "display_url": "on.wsj.com/2RLhnsY",
        "indices": [
          237,
          260
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 48,
  "favorite_count": 63,
  "possibly_sensitive": false,
  "original_created_at": "Wed May 12 21:48:39 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "ジョンソン・アンド・ジョンソン社のCovid-19ワクチンを接種した人の中で、まれではあるが重篤な血栓症が確認されたケースが増加し、初めて男性も含まれた。厚生労働省は、この注射の利点はまだリスクを上回っていると述べている。https://t.co/vZavrNQ8in"
    },
    {
      "locale": "zh",
      "full_text": "强生&amp; 强生公司的Covid-19疫苗接受者中确认的罕见但严重的血液凝结案例已经上升，并首次包括一些男性。卫生官员表示，这种疫苗的好处仍然大于风险。https://t.co/vZavrNQ8in"
    },
    {
      "locale": "zh-Hant",
      "full_text": "強生&amp; 強生公司的Covid-19疫苗接受者中確認的罕見但嚴重的血液凝結案例已經上升，並首次包括一些男性。衛生官員表示，這種疫苗的好處仍然大於風險。https://t.co/vZavrNQ8in"
    }
  ]
}